letetresgene autoleucel
gsk
[]
"this is one of the first clinical trials exploring the t-cell construct for mrcls. i think we ve come to appreciate that a single dose of lete-cel does offer good response rates," tells cgtl. #asco22 
CGTLive™ delivers quality and relevant information to healthcare professionals on cell, gene, regenerative, and engineered medicines to ultimately improve care.